Get the Stockscreener App
336.27
0.63%
2.10
After Hours:
336.27
Penumbra Inc stock is traded at $336.27, with a volume of 370.52K.
It is up +0.63% in the last 24 hours and down -0.71% over the past month.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
See More
Previous Close:
$334.17
Open:
$336.68
24h Volume:
370.52K
Relative Volume:
0.39
Market Cap:
$13.20B
Revenue:
$1.40B
Net Income/Loss:
$177.69M
P/E Ratio:
74.34
EPS:
4.5234
Net Cash Flow:
$174.93M
1W Performance:
-0.58%
1M Performance:
-0.71%
6M Performance:
+34.94%
1Y Performance:
+18.65%
1-Day Range:
$335.06
$336.68
1-Week Range:
$334.17
$338.99
52-Week Range:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
336.27 | 13.11B | 1.40B | 177.69M | 174.93M | 4.5234 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Discipline and Rules-Based Execution in PEN Response - Stock Traders Daily
Congress Asset Management Co. Trims Stake in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (NYSE:PEN) Devices Makes Waves Across Russell 1000 Healthcare Stocks - Kalkine Media
Investment Report: How correlated is Penumbra Inc to the S P5002026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
EV Market: Is Penumbra Inc likely to announce a buybackDollar Strength & Daily Entry Point Trade Alerts - baoquankhu1.vn
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
Bank Watch: What is the long term forecast for Penumbra Inc stockEarnings Overview Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Penumbra Inc (NYSE:PEN) Combines Strong Growth with Bullish Chart Setup - ChartMill
Penumbra, Inc. (PEN): A bull case theory - MSN
Penumbra (PEN) president has 117 shares withheld for RSU tax obligations - Stock Titan
Penumbra (PEN) EVP has 186 shares withheld to cover RSU taxes - Stock Titan
Risk Off: Is Penumbra Inc impacted by rising ratesWeekly Stock Analysis & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
UBS reiterates Penumbra stock rating on thrombectomy confidence By Investing.com - Investing.com India
UBS reiterates Penumbra stock rating on thrombectomy confidence - Investing.com
What Makes Penumbra (PEN) a Good Investment Choice? - Insider Monkey
Delta Global Management LP Acquires 7,896 Shares in Penumbra, Inc. - National Today
Jain Global LLC Boosts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Holocene Advisors LP Makes New Investment in Penumbra, Inc. $PEN - MarketBeat
Delta Global Management LP Purchases Shares of 7,896 Penumbra, Inc. $PEN - MarketBeat
Cinctive Capital Management LP Buys Shares of 6,215 Penumbra, Inc. $PEN - MarketBeat
Bamco Inc. NY Has $3.42 Million Position in Penumbra, Inc. $PEN - MarketBeat
Algert Global LLC Buys 12,830 Shares of Penumbra, Inc. $PEN - MarketBeat
Braidwell LP Has $35.85 Million Stock Position in Penumbra, Inc. $PEN - MarketBeat
Is It Too Late To Consider Penumbra (PEN) After Strong Multi‑Year Share Price Gains? - Yahoo Finance
Integral Health Asset Management LLC Has $12.67 Million Stock Position in Penumbra, Inc. $PEN - MarketBeat
Is It Too Late To Consider Penumbra (PEN) After Strong 1 Year Share Price Gains? - simplywall.st
Magnetar Financial LLC Sells 26,473 Shares of Penumbra, Inc. $PEN - MarketBeat
Capital World Investors Sells 129,455 Shares of Penumbra, Inc. $PEN - MarketBeat
Risk Report: Is Penumbra Inc likely to announce a buybackBreakout Watch & Smart Allocation Stock Reports - baoquankhu1.vn
Can Penumbra Inc. (0P8) stock sustain double digit ROEEntry Point & Daily Risk Controlled Trade Plans - Naître et grandir
Gap Down: What is Penumbra Inc. s debt to equity ratio2025 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Analyst Downgrade: Will Penumbra Inc. stock rally after Fed decisions2025 Dividend Review & Expert Curated Trade Ideas - Naître et grandir
Aug Shorts: What is the long term forecast for Penumbra Inc stock2025 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
Picton Mahoney Asset Management Takes $1.03 Million Position in Penumbra, Inc. $PEN - MarketBeat
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - The Motley Fool
Blood Clot Retrieval Devices Market Size, Share & Forecast to 2036 - Fact.MR
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN) - GuruFocus
Insider Selling: Penumbra (NYSE:PEN) CFO Sells 2,432 Shares of Stock - MarketBeat
Penumbra (PEN) CFO sells 2,432 shares under Rule 10b5-1 plan - Stock Titan
NZS Capital LLC Buys 17,355 Shares of Penumbra, Inc. $PEN - MarketBeat
PEN SEC FilingsPenumbra Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGT - Carroll County Mirror-Democrat
Champlain Investment Partners LLC Trims Holdings in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthc - GuruFocus
Are PEN, STKL, BCO, LNKB Obtaining Fair Deals for their Shareholders? - Finviz
Broker files Form 144 reporting PEN share sales (NYSE: PEN) - Stock Titan
(PEN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise - The Globe and Mail
Penumbra, Inc. (PEN) Stock Analysis: Unveiling the Potential in Medical Devices with a 4.57% Upside - DirectorsTalk Interviews
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):